Mannatech deal
This article was originally published in The Tan Sheet
Executive Summary
Coppell, Tex.-based firm enters into exclusive multi-year supply agreement with Marinova, an Australian biotech firm specializing in biotherapeutics derived from the macro algae Undaria pinnatifida (brown seaweed), Mannatech announces. The contract is "part of an ongoing effort to secure the best and most exclusive worldwide sources of natural, plant-synthesized polysaccharide structures," CEO Sam Caster says. Marinova has developed a method of using a sulphate polysaccharide galactofucan sulphate and created "a patent-pending high-molecular weight fucoidan product," according to a release...